Its smart to ask about the safety of any new therapy, and peptides are no exception
Whether this translates to humans is unresolved, so the label contraindicates it in the highest-risk groups as a precaution
Clinical Trials of IN Administration of Peptides for CNS Therapy Although N-to-B delivery has been well established in clinical trials, improved N-to-B delivery systems have yet to be associated with approved products [6]
A Registered Nurse then takes vital signs
H (400 MHz, CDCl 3 ): 7.97 (1 H, t, J = 5.4 Hz, NH), 7.877.76 (3 H, m, ArH), 7.767.66 (12 H, m, ArH), 3.67 (2 H, s, SCH 2 ), 3.413.25 (2 H, m, PCH 2 ), 3.22 (2 H, apparent q, J = 5.7 Hz, NCH 2 ), 1.771.69 (2 H, m, CH 2 ), 1.671.58 (2 H, m, CH 2 ), 1.581.49 (2 H, m, CH 2 )
Dendrimer-mediated delivery of N-acetyl cysteine to microglia in a mouse model of Rett syndrome